Navigation Links
BioMarin to Present at the William Blair Growth Stock Conference
Date:6/3/2009

NOVATO, Calif., June 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the William Blair Growth Stock Conference in Chicago on Wednesday, June 10, 2009 at 12:00 p.m. CT.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase I clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin(R), N
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
2. BioMarin Provides Grant to NORD to Expand PKU Patient Support Services
3. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
4. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
5. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
6. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
7. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
8. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
9. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
10. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. BioMarin Supports Observance of Rare Disease Day February 28
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... John A. Gennaro, FACHE, MBA, MHSA -- Brings ... Veterans Affairs (VA) is pleased to announce the appointment ... the Cincinnati VA Medical Center (CVAMC). Gennaro will oversee ... Veterans annually and an operating budget of over $387 ... two-division campus located in Cincinnati, Ohio and Fort Thomas, ...
(Date:5/29/2015)... Dot Hill can mark one more item off ... Lake Prince Woods retirement community is the oldest woman to ... , “It was great fun!”, she exclaimed. “I’ve always wanted ... to so they thought this would be ok.” , “We put ... wind tunnel,” she described. “I don’t remember it being noisy, ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, yet ... does no wrong. , It’s fitting, then, that her new ... “God Does No Wrong.” It focuses on what happens when ... , “My story has a positive message about channeling the ... something healing,” Howse said. , “God Does No Wrong” immortalizes ...
(Date:5/29/2015)... May 29, 2015 A group of doctors ... joined the national effort to teach this “new math” to ... U.S. have been “sickened” by the recent implementation of Common ... or hate it, Common Core is now a reality in ... Parents are now seeking ways to improve common core ...
(Date:5/29/2015)... 2015 The print component of “Skin ... of approximately 250,000 and an estimated readership of 750,000. ... social media strategy, and across a network of top ... version of the campaign, click here. , ... Inside, the actress, model and producer details her skin ...
Breaking Medicine News(10 mins):Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Turning grief from a child’s passing into virtue 2Health News:Doctors Discover a Cure for the Common Core 2
... new type of stem cell discovered in the prostate ... cancer, according to a new study by researchers at ... Medical Center and NewYork-Presbyterian Hospital. Led by Michael ... at Columbia University Medical Center, the researchers found the ...
... 9 /PRNewswire-FirstCall/ - The following two issuers (HTDS) ... that further to their previous news releases announcing their ... OTCBB both issuers have retained an SEC qualified auditor ... firm, Mina Mar Group is providing this notice to ...
... , More than 1.3 million Americans go on ... , WASHINGTON, Sept. 9 Leading opponents of government-run health ... for Policy Analysis (NCPA) and Salem Radio Network delivered the more than ... to Congress at a rally held on Capitol Hill. , , ...
... , , , , ... Education Verification (OEV) Program meets the new CMS requirements for verification calls. ... multiple carriers and a variety of plan types. , , ... enrolled members to confirm their intent to enroll in the plan, ensure ...
... ... Cell and Drug DevelopmentTM" including products for use in cancer stem cell research. ... newly developed drugs that block a biological pathway (hedge hog) that drives the proliferation ... ...
... , , ROCHESTER, ... Innovation will host Transform, a collaborative symposium on innovations ... http://centerforinnovation.mayo.edu/transform . Transform will feature nationally recognized ... in health care delivery models, including Web-based tools. The ...
Cached Medicine News:Health News:New type of adult stem cells found in the prostate may be involved in prostate cancer development 2Health News:Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors 2Health News:Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors 3Health News:National Center for Policy Analysis and Salem Radio Network Deliver Million-Plus Signature Petition Opposing Government Run Health Care 2Health News:National Center for Policy Analysis and Salem Radio Network Deliver Million-Plus Signature Petition Opposing Government Run Health Care 3Health News:DSS Research Announces Outbound Education and Verification Program Meets New CMS Requirements 2Health News:Vitro's Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 2Health News:Vitro's Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 3Health News:Vitro's Cancer Stem Cell Therapy Complements New Hedge Hog Drugs 4Health News:Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 2Health News:Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 3Health News:Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 4
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... INDIANAPOLIS , May 29, 2015  Eli Lilly ... AZN ) today announced that they have entered ... and preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint ... Lilly,s VEGF Receptor 2 antiangiogenic cancer medicine. The planned ... patients with advanced solid tumors. The Phase ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and New ... on the benefit of MR/Ultrasound Fusion-Guided Biopsy for ... Prostate Cancer Center at Lenox Hill Hospital is ... System in New York City . We,ve ... risk prostate cancers. The use of an MRI makes for ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... Mass., April 9, 2008 /PRNewswire-FirstCall/ - Echo,Therapeutics ... results,from its human feasibility study of the ... permeation medium for its,Symphony(TM) tCGM System, a ... development for diabetes home use and hospital ...
... April 8, 2008 The Association,for Professionals in ... L. Stricof, MT, MPH, of Albany, NY, has ... DeMille Achievement Award.,APIC presents the annual award to ... the ideals of Carole DeMille, a pioneer,in infection ...
Cached Medicine Technology:Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 2Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 3Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 4Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 5New York Infection Prevention Expert Named Recipient of Carole DeMille Award 2
... As the cornerstone of the revolutionary ... N-595 Pulse Oximeter combines Nellcor's best-in-class ... monitoring platform. The motion-tolerant OxiMax N-595 ... most advanced signal processing technology, which ...
The Model 340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
A pocket-sized pulse oximeter. Perfect for the physician's office, emergency medicine, hospitals and clinics, and home health care....
... The Autocorr Pulse Oximeter with SAC ... unique patented software to extract SpO 2 ... in a new way. This cost-effective ... study functions as standard features, and a ...
Medicine Products: